Medplus Health

  • Market Cap: Small Cap
  • Industry: Retailing
  • ISIN: INE804L01022
  • NSEID: MEDPLUS
  • BSEID: 543427
INR
811.55
-1.9 (-0.23%)
BSENSE

Dec 05

BSE+NSE Vol: 76.61 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
1,679.33
1,542.63
1,509.61
1,561.45
1,576.17
1,488.83
1,490.50
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,679.33
1,542.63
1,509.61
1,561.45
1,576.17
1,488.83
1,490.50
Raw Material Cost
23.41
19.18
19.55
14.24
15.55
12.38
12.25
Purchase of Finished goods
1,220.90
1,052.95
1,136.72
1,106.91
1,083.01
1,245.84
1,163.31
(Increase) / Decrease In Stocks
-4.05
67.61
-47.63
49.43
103.31
-98.65
-21.66
Employee Cost
213.32
200.44
194.17
189.68
180.34
161.82
160.60
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
76.91
71.72
70.42
68.66
69.52
73.67
70.13
Total Expenditure (Excl Depreciation)
1,530.48
1,411.90
1,373.23
1,428.92
1,451.73
1,395.06
1,384.63
Operating Profit (PBDIT) excl Other Income
148.85
130.73
136.38
132.53
124.44
93.77
105.87
Other Income
17.47
15.02
15.79
12.52
11.60
8.71
10.46
Operating Profit (PBDIT)
166.32
145.75
152.17
145.05
136.04
102.48
116.33
Interest
28.82
27.37
26.84
25.97
25.12
24.66
25.13
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
137.50
118.38
125.33
119.08
110.92
77.82
91.20
Depreciation
68.56
65.62
64.21
62.47
63.14
60.03
59.22
Profit Before Tax
68.94
52.77
61.12
56.60
47.78
17.79
31.99
Tax
13.43
10.42
9.80
10.73
9.09
3.44
-1.58
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
55.50
42.34
51.32
45.87
38.70
14.34
33.56
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
55.50
42.34
51.32
45.87
38.70
14.34
33.56
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
-0.02
-0.02
-0.02
-0.04
-0.02
0.17
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
55.50
42.36
51.34
45.89
38.74
14.36
33.40
Equity Capital
23.96
23.95
23.94
23.94
23.91
23.91
23.91
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
4.63
3.54
4.29
3.83
3.24
1.2
2.79
Diluted Earnings per share
4.63
3.53
4.3
3.82
2.23
1.2
2.79
Operating Profit Margin (Excl OI)
8.86%
8.47%
9.03%
8.49%
7.9%
6.3%
7.1%
Gross Profit Margin
8.19%
7.67%
8.3%
7.63%
7.04%
5.23%
6.12%
PAT Margin
3.3%
2.74%
3.4%
2.94%
2.46%
0.96%
2.25%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is 8.86% vs 2.19% in Jun 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is 31.02% vs -17.49% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is 13.86% vs -4.14% in Jun 2025

stock-summary

Interest

QoQ Growth in quarter ended Sep 2025 is 5.30% vs 1.97% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

Compare Quarterly Results Of Medplus Health With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,679.33
2,037.90
-358.57
-17.60%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,679.33
2,037.90
-358.57
-17.60%
Raw Material Cost
23.41
266.08
-242.67
-91.20%
Purchase of Finished goods
1,220.90
724.52
496.38
68.51%
(Increase) / Decrease In Stocks
-4.05
-129.42
125.37
96.87%
Employee Cost
213.32
220.33
-7.01
-3.18%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
76.91
639.66
-562.75
-87.98%
Total Expenditure (Excl Depreciation)
1,530.48
1,721.17
-190.69
-11.08%
Operating Profit (PBDIT) excl Other Income
148.85
316.73
-167.88
-53.00%
Other Income
17.47
21.12
-3.65
-17.28%
Operating Profit (PBDIT)
166.32
337.85
-171.53
-50.77%
Interest
28.82
97.83
-69.01
-70.54%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
137.50
240.02
-102.52
-42.71%
Depreciation
68.56
208.95
-140.39
-67.19%
Profit Before Tax
68.94
31.07
37.87
121.89%
Tax
13.43
7.63
5.80
76.02%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
55.50
23.44
32.06
136.77%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
55.50
23.44
32.06
136.77%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
55.50
23.44
32.06
136.77%
Equity Capital
23.96
1,220.29
-1,196.33
-98.04%
Face Value
2.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
4.63
0.19
4.44
2,336.84%
Diluted Earnings per share
4.63
0.19
4.44
2,336.84%
Operating Profit Margin (Excl OI)
8.86%
15.54%
0.00
-6.68%
Gross Profit Margin
8.19%
11.78%
0.00
-3.59%
PAT Margin
3.30%
1.15%
0.00
2.15%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,679.33 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 8.86% vs 2.19% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 6.54% vs 11.90% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 55.50 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 31.02% vs -17.49% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 43.26% vs 166.07% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 148.85 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 13.86% vs -4.14% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 19.62% vs 46.25% in Sep 2024

Quarterly - Interest
Interest 28.82 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 5.30% vs 1.97% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 14.73% vs 6.71% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.86%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024